EyePoint Pharmaceuticals Inc (EYPT)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-05-19 | 2025-05-19 | B Purchase | Non-Executive Director |
5,000
+15.9%
5.99USD 29,950 |
5,000 +15.9% | 5.99 | USD 29,950 | |
| 2025-05-19 | 2025-05-16 | B Purchase | Non-Executive Director |
5,000
+18.9%
5.81USD 29,050 |
5,000 +18.9% | 5.81 | USD 29,050 | |
| 2025-05-15 | 2025-05-15 | B Purchase | Non-Executive Director |
5,000
+23.3%
5.47USD 27,350 |
5,000 +23.3% | 5.47 | USD 27,350 | |
| 2025-05-15 | 2025-05-14 | B Purchase | Non-Executive Director |
5,000
+30.3%
5.42USD 27,100 |
5,000 +30.3% | 5.42 | USD 27,100 | |
| 2024-08-21 | 2024-08-21 | B Purchase | Non-Executive Director |
5,000
+61.3%
7.95USD 39,750 |
5,000 +61.3% | 7.95 | USD 39,750 | |
| 2024-08-21 | 2024-08-20 | B Purchase | Non-Executive Director |
2,567
+34.7%
7.79USD 19,997 |
2,567 +34.7% | 7.79 | USD 19,997 | |
| 2024-08-21 | 2024-08-19 | B Purchase | Non-Executive Director |
12,500
+312.5%
7.98USD 99,750 |
12,500 +312.5% | 7.98 | USD 99,750 | |
| 2024-08-20 | 2024-08-16 | B Purchase | Non-Executive Director |
3,173
+3.4%
7.88USD 25,003 |
3,173 +3.4% | 7.88 | USD 25,003 | |
| 2024-07-16 | 2024-07-12 | S Sale | Non-Executive Director |
11,625
-86.3%
10.06USD 116,995 |
11,625 -86.3% | 10.06 | USD 116,995 | |
| 2024-06-04 | 2024-06-03 | S Sale | Non-Executive Director |
11,625
-75.9%
10.30USD 119,705 |
11,625 -75.9% | 10.30 | USD 119,705 | |
| 2024-05-16 | 2024-05-14 | S Sale | Non-Executive Director |
11,625
-67.7%
12.65USD 147,045 |
11,625 -67.7% | 12.65 | USD 147,045 | |
| 2024-05-08 | 2024-05-06 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
207,153
+2.6%
12.36USD 2,560,411 |
207,153 +2.6% | 12.36 | USD 2,560,411 | |
| 2024-05-08 | 2024-05-06 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
642,847
+8.6%
11.70USD 7,521,310 |
642,847 +8.6% | 11.70 | USD 7,521,310 | |
| 2024-04-22 | 2024-04-18 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
186,521
+2.6%
18.90USD 3,525,247 |
186,521 +2.6% | 18.90 | USD 3,525,247 | |
| 2024-04-22 | 2024-04-18 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
395,244
+5.7%
17.62USD 6,964,199 |
395,244 +5.7% | 17.62 | USD 6,964,199 | |
| 2024-02-05 | 2024-02-02 | S Sale |
SVP & Chief Commercial Officer Officer |
209
-0.5%
28.49USD 5,954 |
209 -0.5% | 28.49 | USD 5,954 | |
| 2024-01-30 | 2024-01-26 | S Sale |
Chief Medical Officer Officer |
33,665
-48.0%
25.77USD 867,672 |
33,665 -48.0% | 25.77 | USD 867,672 | |
| 2024-01-30 | 2024-01-26 | S Sale |
Chief Medical Officer Officer |
15,609
-18.2%
25.41USD 396,572 |
15,609 -18.2% | 25.41 | USD 396,572 | |
| 2024-01-30 | 2024-01-26 | S Sale |
Chief Medical Officer Officer |
51
-0.1%
25.41USD 1,296 |
51 -0.1% | 25.41 | USD 1,296 | |
| 2024-01-29 | 2024-01-26 | S Sale |
SVP & Chief Commercial Officer Officer |
9,604
-20.2%
25.27USD 242,717 |
9,604 -20.2% | 25.27 | USD 242,717 |